Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


12 Nov 2016 - 16 Nov 2016
16 Nov 2016 - 19 Nov 2016

New Larger Volume Extraction System Increases Productivity and Sensitivity

By BiotechDaily International staff writers
Posted on 30 Jun 2014
Print article
ISOLUTE SLE+ One Milliliter Supported Liquid Extraction
One Milliliter Supported Liquid Extraction (Photo courtesy of BIOTAGE AB )
Biotechnology and other life science researchers now have available an extraction system for larger volumes that prepares samples of up to one milliliter for LC-MS/MS (liquid chromatography-mass spectroscopy) or GC-MS (gas chromatography-mass spectroscopy) analysis.

The Biotage (Uppsala, Sweden) ISOLUTE SLE+ One Milliliter Supported Liquid Extraction 48-well plate system enables the extraction of larger sample volumes (one milliliter total load volume) than is presently possible in the standard microplate format.

The new format tubes are packed with ISOLUTE SLE+ material, with each well containing sufficient ISOLUTE SLE+ material to efficiently extract one milliliter of aqueous sample. This is an alternative to the existing 96-well formats, which have a maximum capacity of 400 microliters. Larger sample volumes enable the researcher to generate higher sensitivity, higher throughput, and lower detection limits.

The ISOLUTE SLE+ plate is arranged in a six by eight array; with 48 samples being processed per plate. A new compatible 48-well collection plate is also available with a five milliliter capacity so that the entire elution solvent volume can be collected with no need to swap collection vessels.

The plates can be processed using microplate compatible positive pressure manifolds such as the Biotage Pressure+ 96, vacuum manifolds such as the Biotage VacMaster 96, and most automated liquid handling systems.

ISOLUTE SLE+ plates are ideal for the extraction of small molecule drugs, metabolites, and endogenous biomarkers from biological fluid samples prior to analytical techniques such as LC-MS/MS and GC-MS.

Related Links:


Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to BiotechDaily.com and get complete access to news and events that shape the world of biotechnology.
  • Free digital version edition of Bio Research International sent by email on regular basis
  • Free print version of Bio Research International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Bio Research International in digital format
  • Free Bio Research International Newsletter sent every 2 weeks containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
Click here to Register


Drug Discovery

view channel
Image: Positive alpha-synuclein staining of a Lewy body from a patient with Parkinson\'s disease (Photo courtesy of Wikimedia Commons).

Bifunctional Dimer Drugs Prove Effective in Parkinson's Disease Yeast Model

A team of Canadian neurodegenerative disease researchers used a yeast model system to identify novel drug compounds that were able to block the misfolding of alpha- synuclein (AS) protein, which characterizes... Read more


view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more


view channel

Collaborative Agreement to Aid in Setting Guidelines for Evaluating Potential Ebola Therapy

Cooperation between an Israeli biopharmaceutical company and medical branches of the US government is designed to set ground rules for continued evaluation of an experimental therapy for Ebola virus disease. RedHill Biopharma Ltd. (Tel Aviv, Israel), a biopharmaceutical company primarily focused on development and c... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.